Literature DB >> 33020951

Comparison of commercially available 0.2% chlorhexidine mouthwash with and without anti-discoloration system: A blinded, crossover clinical trial.

Erik Klepsland Mauland1, Hans R Preus1, Anne Merete Aass1.   

Abstract

AIM: To evaluate clinical performance and side effects of two commercially available 0.2% chlorhexidine mouthwashes after periodontal surgery, one with (test) and one without (control) an anti-discoloration system.
MATERIALS AND METHODS: This single-centre, crossover clinical trial included 38 patients undergoing two sessions of periodontal flap surgery. The participants used two different 0.2% chlorhexidine products, one with and one without an anti-discoloration system, in the 14-day post-operative periods. Plaque, gingival inflammation, tooth staining, side effects and patient preference were evaluated.
RESULTS: The control mouthwash (without an anti-discolouring system) produced significantly lower plaque (p = 0.02) and gingival index (p = 0.01) compared to the test mouthwash. The test mouthwash produced significantly less staining in the gingival (p = 0.002) and approximal areas (p = 0.0004), but no difference was detected in the buccal area of the teeth. The patients did not show preference for any of the mouthwashes.
CONCLUSION: Chlorhexidine mouthwash without an anti-discoloration system resulted in significantly lowered plaque and gingival index compared to chlorhexidine mouthwash with an anti-discoloration following periodontal surgery. No difference in patient preference was found despite less side effects produced by the chlorhexidine mouthwash with the anti-discoloration system.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  chlorhexidine; discoloration; mouthwash; periodontal surgery; staining

Mesh:

Substances:

Year:  2020        PMID: 33020951     DOI: 10.1111/jcpe.13382

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  1 in total

1.  Inhibitory effect of carboxylated nanodiamond on oral pathogenic bacteria Streptococcus mutans.

Authors:  Chuntian Quan; Haiyan Lin; Hui Xiao; Jianjiang Zhao
Journal:  J Clin Lab Anal       Date:  2021-07-19       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.